Drug intelligence / Profile preview

Alexitol sodium

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Alexitol sodium is an antacid classified as a poly(hydroxyaluminium) carbonate-hexitol complex. It is used to treat indigestion, heartburn, and ulcers by neutralizing gastric acid in the stomach. The compound reacts with hydrochloric acid to form water and neutral salts (such as sodium chloride), thereby reducing acidity and providing symptomatic relief from gastrointestinal discomfort[1][2][3]. It is primarily available in oral formulations and may be found in combination products for digestive health.

Brand names: ActalAcriflex
Other names: Alexitol sodicoAlexitol sodiqueAlexitolum natricumAlexitol sodium [INN:BAN]ALEXITOL SODIUM [MI]ALEXITOL SODIUM [MART.]ALEXITOL SODIUM [WHO-DD]aluminum;sodium;hexane-1,2,3,4,5,6-hexol;carbonate;hydroxidealexitol de sodio

Beyond the preview

Go deeper on Alexitol sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alexitol sodium.

Explore the full profile